Healthcare M&A Due Diligence: The Blueprints For Success
“For senior leaders and investors, the acquisition process asks many questions and poses complexities on all fronts.”
Why Healthcare M&A Due Diligence Is Important
Healthcare mergers and acquisitions are now a primary driver of sector advancement globally. For providers expanding at scale, the benefits range from advanced technology integration to centralised governance, proposing prospects that some smaller providers perhaps wouldn’t have had access to before. However, the success of these ventures hinges on healthcare M&A due diligence.
For senior leaders and investors, the acquisition process asks many questions and poses complexities on all fronts. Every site carries different risks surrounding local commissioning, regulatory history and governance in practice, which ultimately position the final investment decision.
To mitigate these risks, providers often make use of external expertise, namely former regulators and governance specialists, to help achieve an objective assessment of a service’s culture, compliance, and potential.
This article will define the key pillars of a thorough, regulatory-informed M&A due diligence assessment that supports stability before a decision is made and during the post-acquisition period.
Review Of Regulatory History
Simply reviewing a CQC or Care Inspectorate rating is a rigid, misleading approach.
A thorough due diligence process audits the governance systems and compliance culture that created the rating. With recurring themes identified regarding enforcement and response, investors and teams can map out a streamlined post-acquisition strategy that puts stability and the continuity of care forward as a priority.
Staffing Records and Capability
In healthcare, competence is the baseline, but Registered Manager (RM) stability is a huge asset. A robust due diligence approach recognizes patterns in staffing levels, leadership visibility, and the instilled culture.
In healthcare, staff competence is the baseline, but stability and support towards and from the Registered Manager is an asset. A robust approach to due diligence recognises patterns in staffing levels, leadership visibility and the instilled culture.
Thorough Risk Assessments
Compliance gaps are rarely incidental; they are symptoms of the preceding systems. By utilizing regulatory-informed reporting, experts can recognize where potential risks begin, often in governance and documentation, before they become enforcement actions or poor CQC ratings.
Identifying these early indicators allows for a proactive approach to governance. Protecting the provider and investment from sudden issues if acted on throughout the acquisition process.
Regulatory-informed Reporting For Healthcare M&A Due Diligence
Following due diligence assessments, a top-down assessment of quality of care will shape the acquisition process moving forward.
The process should involve feedback from residents/patients, staff, and any involved stakeholders in relation to service standards and quality. Reports should detail gaps and patterns in compliance, outlining plans for these potential risks to be mitigated during the acquisition period.
Crucially, assessments should look beyond written governance. Most leaders and Registered Managers understand what good governance looks like, but what matters is how that is performed on operational fronts. This paints a true picture of the service and positions the decision of investors.
Position your decision, protect your portfolio. Our healthcare M&A due diligence assessments are informed by the expertise of a former CQC regulator. Contact us today to see how we can support your next acquisition process.
